Chemotherapy-naive unresectable or recurrent pancreatic cancer
Conditions
Interventions
Sponsors
Kawasaki Medical School Department of Clinical Oncology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Histologically-defined panreatic cancer 2) Measurable lesion 3) un-treated 4) Age 20-80 5) PS 0-2 6) Estimated prognosis >= 3 months 7) Sufficient organ function WBC>4,000/mm3, <12,000/mm3 NE>2,000/mm3 PLT>100.000/mm3 Hg>10.0g/dl GOT/GPT<Normal range x 2 Bil<1.5mg/dl Creat<1.5mg/dl 8) Written informed consent 9) No pregnancy
Exclusion criteria
Exclusion criteria: 1) Autoimmune disease 2) Uncontrollable complications including infection, diabetes, hypertension, ischemic heart disease, cerebral infarction, interstitial pneumonitis, cancer pain 3) Pregnancy 4) Allergy 5) General symptoms including dyspnea, jaundice, edema, effusions, clamp, paralysis, fracture, difficult for out-patient 6) Double cancer 7) Other cancer treatment 8) Steroid or immunosuppressive agents 9) Other unacceptable reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS: progression free survival | — |
Countries
Japan
Contacts
Public ContactYoshiyuki YAMAGUCHI
Kawasaki Medical School Department of Clinical Oncology
Outcome results
None listed